chr9-134815988-G-A

Variant names:

• chr9-134815988-G-A
• rs3827848
• NM_000093.5:c.4122G>A

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 0P and 18B. BP4_Moderate BP6_Very_Strong BA1

The NM_000093.5(COL5A1):​c.4122G>A​(p.Thr1374Thr) variant causes a splice region, synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.152 in 1,613,610 control chromosomes in the GnomAD database, including 19,278 homozygotes. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).

• Frequency:
  • Genomes: 𝑓 0.14 (1608 hom., cov: 33)
  • Exomes 𝑓: 0.15 (17670 hom.)
• Consequence: COL5A1 NM_000093.5 splice_region, synonymous
• Scores: Splicing: ADA: 0.9565
• Clinical Significance: Benign/Likely benign criteria provided, multiple submitters, no conflicts B:13
• Conservation: PhyloP100: 1.23

Genes affected

COL5A1 (HGNC:2209): (collagen type V alpha 1 chain) This gene encodes an alpha chain for one of the low abundance fibrillar collagens. Fibrillar collagen molecules are trimers that can be composed of one or more types of alpha chains. Type V collagen is found in tissues containing type I collagen and appears to regulate the assembly of heterotypic fibers composed of both type I and type V collagen. This gene product is closely related to type XI collagen and it is possible that the collagen chains of types V and XI constitute a single collagen type with tissue-specific chain combinations. The encoded procollagen protein occurs commonly as the heterotrimer pro-alpha1(V)-pro-alpha1(V)-pro-alpha2(V). Mutations in this gene are associated with Ehlers-Danlos syndrome, types I and II. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2013]

ACMG classification

Our verdict: Benign. The variant received -18 ACMG points.

• BP4: Computational evidence support a benign effect (BayesDel_noAF=-0.31).
• BP6: Variant 9-134815988-G-A is Benign according to our data. Variant chr9-134815988-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 136889.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-134815988-G-A is described in Lovd as [Benign].
• BA1: GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.159 is higher than 0.05.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	MANE	Protein	UniProt
COL5A1	NM_000093.5	c.4122G>A	p.Thr1374Thr	splice_region_variant, synonymous_variant	Exon 52 of 66	ENST00000371817.8	NP_000084.3
COL5A1	NM_001278074.1	c.4122G>A	p.Thr1374Thr	splice_region_variant, synonymous_variant	Exon 52 of 66		NP_001265003.1
COL5A1	XM_017014266.3	c.4122G>A	p.Thr1374Thr	splice_region_variant, synonymous_variant	Exon 52 of 65		XP_016869755.1

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	TSL	MANE	Protein	Appris	UniProt
COL5A1	ENST00000371817.8	c.4122G>A	p.Thr1374Thr	splice_region_variant, synonymous_variant	Exon 52 of 66	1	NM_000093.5	ENSP00000360882.3
COL5A1	ENST00000371820.4	c.4122G>A	p.Thr1374Thr	splice_region_variant, synonymous_variant	Exon 52 of 66	2		ENSP00000360885.4

Frequencies

GnomAD3 genomes AF: 0.140 AC: 21362 AN: 152044 Hom.: 1606 Cov.: 33

Gnomad AFR AF: 0.110

Gnomad AMI AF: 0.0844

Gnomad AMR AF: 0.110

Gnomad ASJ AF: 0.110

Gnomad EAS AF: 0.163

Gnomad SAS AF: 0.133

Gnomad FIN AF: 0.182

Gnomad MID AF: 0.136

Gnomad NFE AF: 0.161

Gnomad OTH AF: 0.128

GnomAD2 exomes AF: 0.147 AC: 36952 AN: 251360 AF XY: 0.147

Gnomad AFR exome AF: 0.105

Gnomad AMR exome AF: 0.107

Gnomad ASJ exome AF: 0.112

Gnomad EAS exome AF: 0.172

Gnomad FIN exome AF: 0.180

Gnomad NFE exome AF: 0.160

Gnomad OTH exome AF: 0.141

GnomAD4 exome AF: 0.153 AC: 223574 AN: 1461448 Hom.: 17670 Cov.: 34 AF XY: 0.153 AC XY: 111168 AN XY: 727038

Gnomad4 AFR exome AF: 0.106 AC: 3561 AN: 33474

Gnomad4 AMR exome AF: 0.105 AC: 4687 AN: 44722

Gnomad4 ASJ exome AF: 0.108 AC: 2829 AN: 26132

Gnomad4 EAS exome AF: 0.150 AC: 5936 AN: 39692

Gnomad4 SAS exome AF: 0.137 AC: 11819 AN: 86246

Gnomad4 FIN exome AF: 0.184 AC: 9796 AN: 53338

Gnomad4 NFE exome AF: 0.158 AC: 175113 AN: 1111700

Gnomad4 Remaining exome AF: 0.150 AC: 9046 AN: 60378

GnomAD4 genome AF: 0.141 AC: 21386 AN: 152162 Hom.: 1608 Cov.: 33 AF XY: 0.139 AC XY: 10307 AN XY: 74390

Gnomad4 AFR AF: 0.110 AC: 0.109586 AN: 0.109586

Gnomad4 AMR AF: 0.110 AC: 0.110079 AN: 0.110079

Gnomad4 ASJ AF: 0.110 AC: 0.109862 AN: 0.109862

Gnomad4 EAS AF: 0.163 AC: 0.163376 AN: 0.163376

Gnomad4 SAS AF: 0.134 AC: 0.134384 AN: 0.134384

Gnomad4 FIN AF: 0.182 AC: 0.181844 AN: 0.181844

Gnomad4 NFE AF: 0.161 AC: 0.161225 AN: 0.161225

Gnomad4 OTH AF: 0.130 AC: 0.130435 AN: 0.130435

Alfa AF: 0.152 Hom.: 5983

Bravo AF: 0.132

Asia WGS AF: 0.144 AC: 503 AN: 3478

EpiCase AF: 0.152

EpiControl AF: 0.150

ClinVar

Significance: Benign/Likely benign

Submissions summary: Benign:13

Revision: criteria provided, multiple submitters, no conflicts

Submissions by phenotype

not specified Benign:5

Nov 13, 2012

GeneDx

Significance: Benign

Review Status: criteria provided, single submitter

Collection Method: clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-

Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen

Significance: Benign

Review Status: no assertion criteria provided

Collection Method: clinical testing

- -

-

Genome Diagnostics Laboratory, Amsterdam University Medical Center

Significance: Benign

Review Status: no assertion criteria provided

Collection Method: clinical testing

- -

-

PreventionGenetics, part of Exact Sciences

Significance: Benign

Review Status: criteria provided, single submitter

Collection Method: clinical testing

- -

Apr 09, 2025

Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, Montreal Heart Institute

Significance: Benign

Review Status: criteria provided, single submitter

Collection Method: clinical testing

- -

not provided Benign:3

-

Breakthrough Genomics, Breakthrough Genomics

Significance: Likely benign

Review Status: criteria provided, single submitter

Collection Method: not provided

- -

Mar 10, 2017

Women's Health and Genetics/Laboratory Corporation of America, LabCorp

Significance: Benign

Review Status: criteria provided, single submitter

Collection Method: clinical testing

Variant summary: The COL5A1 c.4122G>A (p.Thr1374Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide, resulting in a synonymous change. One in silico tool predicts a polymorphism outcome for this variant. 5/5 splice prediction tools predict weakening the canonical donor cite. However, these predictions have yet to be confirmed by functional studies. This variant was found in 17922/121286 control chromosomes (1465 homozygotes) at a frequency of 0.1477664, which is approximately 118213 times the estimated maximal expected allele frequency of a pathogenic COL5A1 variant (0.0000013), suggesting this variant is likely a benign polymorphism. In addition, multiple clinical diagnostic laboratories/reputable databases classified this variant as benign. Taken together, this variant is classified as benign. -

Nov 27, 2024

ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories

Significance: Benign

Review Status: criteria provided, single submitter

Collection Method: clinical testing

- -

Ehlers-Danlos syndrome, classic type, 1 Benign:2

Mar 15, 2022

Genome-Nilou Lab

Significance: Benign

Review Status: criteria provided, single submitter

Collection Method: clinical testing

- -

Feb 04, 2025

Labcorp Genetics (formerly Invitae), Labcorp

Significance: Benign

Review Status: criteria provided, single submitter

Collection Method: clinical testing

- -

Fibromuscular dysplasia, multifocal Benign:1

Mar 15, 2022

Genome-Nilou Lab

Significance: Benign

Review Status: criteria provided, single submitter

Collection Method: clinical testing

- -

Familial thoracic aortic aneurysm and aortic dissection Benign:1

Feb 04, 2015

Ambry Genetics

Significance: Benign

Review Status: criteria provided, single submitter

Collection Method: clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Ehlers-Danlos syndrome type 7A Benign:1

Jun 14, 2016

Illumina Laboratory Services, Illumina

Significance: Likely benign

Review Status: criteria provided, single submitter

Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name	Calibrated prediction	Score	Prediction
BayesDel_noAF	Benign	-0.31
CADD	Benign	19
DANN	Benign	0.88
Mutation Taster		=38/62	polymorphism (auto)

Splicing

Name	Calibrated prediction	Score	Prediction
dbscSNV1_ADA	Benign	0.96
dbscSNV1_RF	Benign	0.28
SpliceAI score (max)		0.30		Details are displayed if max score is > 0.2
DS_DL_spliceai		0.30		Position offset: 0

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Other links and lift over

dbSNP: rs3827848; hg19: chr9-137707834; COSMIC: COSV65666835;